These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

245 related items for PubMed ID: 24864241

  • 1. Leczyme: a new candidate drug for cancer therapy.
    Tatsuta T, Sugawara S, Takahashi K, Ogawa Y, Hosono M, Nitta K.
    Biomed Res Int; 2014; 2014():421415. PubMed ID: 24864241
    [Abstract] [Full Text] [Related]

  • 2. Sialic acid-binding lectin (leczyme) induces apoptosis to malignant mesothelioma and exerts synergistic antitumor effects with TRAIL.
    Tatsuta T, Hosono M, Takahashi K, Omoto T, Kariya Y, Sugawara S, Hakomori S, Nitta K.
    Int J Oncol; 2014 Feb; 44(2):377-84. PubMed ID: 24297392
    [Abstract] [Full Text] [Related]

  • 3. Downregulation of Hsp70 inhibits apoptosis induced by sialic acid-binding lectin (leczyme).
    Tatsuta T, Hosono M, Ogawa Y, Inage K, Sugawara S, Nitta K.
    Oncol Rep; 2014 Jan; 31(1):13-8. PubMed ID: 24173532
    [Abstract] [Full Text] [Related]

  • 4. RNase activity of sialic acid-binding lectin from bullfrog eggs drives antitumor effect via the activation of p38 MAPK to caspase-3/7 signaling pathway in human breast cancer cells.
    Kariya Y, Tatsuta T, Sugawara S, Kariya Y, Nitta K, Hosono M.
    Int J Oncol; 2016 Oct; 49(4):1334-42. PubMed ID: 27513956
    [Abstract] [Full Text] [Related]

  • 5. Sialic acid-binding lectin (leczyme) induces caspase-dependent apoptosis-mediated mitochondrial perturbation in Jurkat cells.
    Tatsuta T, Hosono M, Sugawara S, Kariya Y, Ogawa Y, Hakomori S, Nitta K.
    Int J Oncol; 2013 Nov; 43(5):1402-12. PubMed ID: 24008724
    [Abstract] [Full Text] [Related]

  • 6. Cancer-selective induction of apoptosis by leczyme.
    Tatsuta T, Sugawara S, Takahashi K, Ogawa Y, Hosono M, Nitta K.
    Front Oncol; 2014 Nov; 4():139. PubMed ID: 24926439
    [Abstract] [Full Text] [Related]

  • 7. Ribonuclease activity of sialic acid-binding lectin from Rana catesbeiana eggs.
    Nitta K, Oyama F, Oyama R, Sekiguchi K, Kawauchi H, Takayanagi Y, Hakomori S, Titani K.
    Glycobiology; 1993 Feb; 3(1):37-45. PubMed ID: 8448385
    [Abstract] [Full Text] [Related]

  • 8. Inhibition of cell proliferation by Rana catesbeiana and Rana japonica lectins belonging to the ribonuclease superfamily.
    Nitta K, Ozaki K, Ishikawa M, Furusawa S, Hosono M, Kawauchi H, Sasaki K, Takayanagi Y, Tsuiki S, Hakomori S.
    Cancer Res; 1994 Feb 15; 54(4):920-7. PubMed ID: 8313382
    [Abstract] [Full Text] [Related]

  • 9. Involvement of ER stress in apoptosis induced by sialic acid-binding lectin (leczyme) from bullfrog eggs.
    Tatsuta T, Hosono M, Miura Y, Sugawara S, Kariya Y, Hakomori S, Nitta K.
    Int J Oncol; 2013 Dec 15; 43(6):1799-808. PubMed ID: 24100413
    [Abstract] [Full Text] [Related]

  • 10. Discovery of antitumor effects of leczymes.
    Tatsuta T, Hosono M.
    Glycoconj J; 2022 Apr 15; 39(2):157-165. PubMed ID: 35066741
    [Abstract] [Full Text] [Related]

  • 11. Sialyl-glycoconjugates in cholesterol-rich microdomains of P388 cells are the triggers for apoptosis induced by Rana catesbeiana oocyte ribonuclease.
    Ogawa Y, Sugawara S, Tatsuta T, Hosono M, Nitta K, Fujii Y, Kobayashi H, Fujimura T, Taka H, Koide Y, Hasan I, Matsumoto R, Yasumitsu H, Kanaly RA, Kawsar SM, Ozeki Y.
    Glycoconj J; 2014 Feb 15; 31(2):171-84. PubMed ID: 24271942
    [Abstract] [Full Text] [Related]

  • 12. Sialic Acid-Binding Lectin from Bullfrog Eggs Exhibits an Anti-Tumor Effect Against Breast Cancer Cells Including Triple-Negative Phenotype Cells.
    Tatsuta T, Sato S, Sato T, Sugawara S, Suzuki T, Hara A, Hosono M.
    Molecules; 2018 Oct 21; 23(10):. PubMed ID: 30347895
    [Abstract] [Full Text] [Related]

  • 13. Effect of modification of the carboxyl groups of the sialic acid binding lectin from bullfrog (Rana catesbeiana) oocyte on anti-tumor activity.
    Iwama M, Ogawa Y, Sasaki N, Nitta K, Takayanagi Y, Ohgi K, Tsuji T, Irie M.
    Biol Pharm Bull; 2001 Sep 21; 24(9):978-81. PubMed ID: 11558580
    [Abstract] [Full Text] [Related]

  • 14. [Basic Research on Bullfrog Egg-derived Sialic Acid-binding Lectin for Cancer Treatment].
    Tatsuta T.
    Yakugaku Zasshi; 2022 Sep 21; 142(10):1045-1053. PubMed ID: 36184438
    [Abstract] [Full Text] [Related]

  • 15. Characterization of a Rana catesbeiana lectin-resistant mutant of leukemia P388 cells.
    Nitta K, Ozaki K, Tsukamoto Y, Furusawa S, Ohkubo Y, Takimoto H, Murata R, Hosono M, Hikichi N, Sasaki K.
    Cancer Res; 1994 Feb 15; 54(4):928-34. PubMed ID: 8313383
    [Abstract] [Full Text] [Related]

  • 16. Sialic acid-binding lectin from bullfrog eggs inhibits human malignant mesothelioma cell growth in vitro and in vivo.
    Tatsuta T, Satoh T, Sugawara S, Hara A, Hosono M.
    PLoS One; 2018 Feb 15; 13(1):e0190653. PubMed ID: 29298350
    [Abstract] [Full Text] [Related]

  • 17. Onconase and amphinase, the antitumor ribonucleases from Rana pipiens oocytes.
    Ardelt W, Shogen K, Darzynkiewicz Z.
    Curr Pharm Biotechnol; 2008 Jun 15; 9(3):215-25. PubMed ID: 18673287
    [Abstract] [Full Text] [Related]

  • 18. Leczyme.
    Nitta K.
    Methods Enzymol; 2001 Jun 15; 341():368-74. PubMed ID: 11582791
    [No Abstract] [Full Text] [Related]

  • 19. Comparative base specificity, stability, and lectin activity of two lectins from eggs of Rana catesbeiana and R. japonica and liver ribonuclease from R. catesbeiana.
    Okabe Y, Katayama N, Iwama M, Watanabe H, Ohgi K, Irie M, Nitta K, Kawauchi H, Takayanagi Y, Oyama F.
    J Biochem; 1991 May 15; 109(5):786-90. PubMed ID: 1917903
    [Abstract] [Full Text] [Related]

  • 20. Isolation and characterization of Rana catesbeiana lectin and demonstration of the lectin-binding glycoprotein of rodent and human tumor cell membranes.
    Nitta K, Takayanagi G, Kawauchi H, Hakomori S.
    Cancer Res; 1987 Sep 15; 47(18):4877-83. PubMed ID: 3497712
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.